These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8921254

  • 1. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
    Watanabe D, Yoshimura R, Khalil M, Yoshida K, Kishimoto T, Taga T, Kiyama H.
    Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1996 Jun 21; 271(25):14764-72. PubMed ID: 8662918
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep 21; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 7. The soluble interleukin-6 receptor.
    Rose-John S, Ehlers M, Grötzinger J, Müllberg J.
    Ann N Y Acad Sci; 1995 Jul 21; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract] [Full Text] [Related]

  • 8. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 9. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
    Di Marco A, Gloaguen I, Demartis A, Saggio I, Graziani R, Paonessa G, Laufer R.
    J Biol Chem; 1997 Sep 12; 272(37):23069-75. PubMed ID: 9287306
    [Abstract] [Full Text] [Related]

  • 10. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S.
    Science; 1994 Jan 07; 263(5143):92-5. PubMed ID: 8272873
    [Abstract] [Full Text] [Related]

  • 11. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
    Ito Y, Yamamoto M, Mitsuma N, Li M, Hattori N, Sobue G.
    Neurochem Res; 2001 Jan 07; 26(1):51-8. PubMed ID: 11358282
    [Abstract] [Full Text] [Related]

  • 12. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H.
    J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424
    [Abstract] [Full Text] [Related]

  • 13. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A, Pflanz S, Grötzinger J, Küster A, Kurth I, Pitard V, Heinrich PC, Müller-Newen G.
    FEBS Lett; 2000 Feb 25; 468(2-3):120-4. PubMed ID: 10692570
    [Abstract] [Full Text] [Related]

  • 14. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.
    Di Marco A, Gloaguen I, Graziani R, Paonessa G, Saggio I, Hudson KR, Laufer R.
    Proc Natl Acad Sci U S A; 1996 Aug 20; 93(17):9247-52. PubMed ID: 8799186
    [Abstract] [Full Text] [Related]

  • 15. Cloning and characterization of a specific receptor for mouse oncostatin M.
    Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA.
    Mol Cell Biol; 1998 Jun 20; 18(6):3357-67. PubMed ID: 9584176
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 20; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

  • 17. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.
    Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD.
    Science; 1993 Jun 18; 260(5115):1805-8. PubMed ID: 8390097
    [Abstract] [Full Text] [Related]

  • 18. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.
    Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716
    [Abstract] [Full Text] [Related]

  • 19. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.
    J Biol Chem; 2000 Feb 25; 275(8):5648-56. PubMed ID: 10681548
    [Abstract] [Full Text] [Related]

  • 20. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
    Tacken I, Dahmen H, Boisteau O, Minvielle S, Jacques Y, Grötzinger J, Küster A, Horsten U, Blanc C, Montero-Julian FA, Heinrich PC, Müller-Newen G.
    Eur J Biochem; 1999 Oct 25; 265(2):645-55. PubMed ID: 10504396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.